Nicaise Ndembi
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
12-08-2025
- Associated Press
Organizational Leader and Business Strategist Kyle Kinzie Named President & Partner, Hospitals & Healthcare Delivery Solutions at Slone Partners
New executive will focus on building out new partnerships in the healthcare delivery sector SOUTH RIDING, Va., Aug. 12, 2025 /PRNewswire/ -- Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced that renowned senior executive and organizational leader Kyle Kinzie has joined the company as President & Partner, Hospitals & Healthcare Delivery Solutions. Kinzie brings more than 20 years of diversified experience scaling and generating profit growth for an array of innovative organizations ranging from startups to Fortune 500 companies. He is recognized as a well-rounded and inspirational cross-functional team leader with an impressive history of expanding the scope and impact of business units in various sectors. In his new role at Slone Partners, Kinzie will focus on expanding the company's retained and interim search footprint within the healthcare delivery sector including hospitals, academic health systems, outpatient clinics, and ambulatory care centers. He will further our efforts to build out this industry, leveraging the firm's strong foundation of client partner relationships and referrals. 'Kyle Kinzie is a remarkably dynamic and innovative strategic leader with a penchant for driving growth across key business verticals – from healthcare to talent management. I'm impressed with his track record and entrepreneurial mindset,' said Slone Partners co-CEO and Managing Partner Leslie Loveless. 'He joins our team as we seek out new partnerships and clients to expand our impact in the healthcare delivery space.' 'We are excited to welcome Kyle to Slone Partners as we head toward our second quarter century delivering premier talent to innovative life sciences and healthcare organizations,' said co-CEO and Managing Partner Eric Fink. 'Kyle brings an infectious energy and spirit to every project he is involved in, and I see this as a tremendous opportunity for him to scale our healthcare delivery practice at a time when organizations across the healthcare spectrum face increasing pressure to secure passionate and visionary leaders.' 'I'm thrilled to join the outstanding team at Slone Partners,' said Kinzie. 'We have an incredible legacy in life sciences and healthcare, and I'm eager to build on that success by focusing on growth in healthcare delivery—placing visionary leaders in hospitals, health systems, and outpatient organizations. As the industry navigates unprecedented challenges and rapid change, exceptional leadership will be more critical than ever. We have a real opportunity to help organizations strengthen their teams and elevate care across the continuum.' Prior to joining Slone Partners, Kinzie served as Vice President at Health Carousel, a healthcare staffing and workforce solutions organization. During his four years with Health Carousel, he played a key role in the company's growth, leading Health Carousel to a #15 ranking in the 2025 Overall US Firms as reported in the Staffing Industry Analysts (SIA) rankings, up from #16 in 2024, while also maintaining the top position as the #1 International Staffing Firm for the third consecutive year. Kinzie is recognized for his innovative approach to client engagement with extensive experience spanning private equity, public companies, and founder-led ventures. He combines operational excellence and market insight to position organizations for growth, industry influence, and successful outcomes. His past roles include Chief Revenue Officer at Crisp Media Group, SVP at Upswell Marketing, and Vice President and Partner at First Billing. Kinzie graduated Magna Cum Laude with a Bachelor's Degree in Marketing and Finance from Miami University. ABOUT SLONE PARTNERS Celebrating its 25th year, Slone Partners is a premier executive search and talent advisory firm delivering visionary leaders and fractional talent who build and scale amazing life sciences and healthcare organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals. To learn more about Slone Partners' value proposition and our many success stories, visit or call 888.784.3422. View original content to download multimedia: SOURCE Slone Partners
Fast Company
21-07-2025
- Fast Company
These are the keys to good strategic partnerships that can future-proof your business
Hello and welcome to Modern CEO! I'm Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from conversations with executives and entrepreneurs, and from the pages of Inc. and Fast Company. If you received this newsletter from a friend, you can sign up to get it yourself every Monday morning. Modern business is built on partnerships. Some 43% of mid-market executives surveyed by J.P. Morgan at the end of last year said they were planning to invest in strategic alliances in 2025 as part of their growth plans. A third of Fast Company's Most Innovative Companies surveyed in 2023 said they were looking at initiating partnerships with third parties to maintain their innovation readiness. What does it take to make such partnerships work? 'You need humility and the willingness to take a risk on behalf of the partner so that both sides have skin in the game,' says Steve Beard, chairman and CEO of Adtalem Global Education, a for-profit provider of education and training for the healthcare industry. Finding solutions together Adtalem, which reported $1.6 billion in sales in fiscal 2024, up 9.2% from a year earlier, routinely partners with schools, hospital systems, and training organizations to increase its pipeline of medical professionals and offer hands-on experience to students and graduates. Beard shared the example of a new alliance between Chamberlain University, one of Adtalem's nursing schools, and SSM Health, a nonprofit health system operating in Illinois, Missouri, Oklahoma, and Wisconsin. The arrangement aims to enroll 400 nurses annually, primarily in Chamberlain's online Bachelor of Science in Nursing (BSN) program. Students in the program have the opportunity to gain work experience at SSM Health facilities while in school and have access to full-time employment opportunities at SSM Health—with loan repayment—upon graduation. Beard and Amy Wilson, chief nurse executive of SSM Health, say the program is designed to help address a nursing shortage in the U.S. The Bureau of Labor Statistics is projecting nearly 200,000 nursing openings each year through 2032 due to retirements—but the size of the registered nurse population is only expected to grow by 177,400 nurses between 2022 and 2032. Chamberlain recruits 'nontraditional' students, including people whose educations have been interrupted or those who have been shut out of selective colleges and universities. The school says it is the No. 1 provider of nursing degrees to minority students. 'Prestige and selectivity are, by definition, intended to be small, and there's no incentive for those institutions to grow to meet the market demand, which creates a very attractive lane for us,' says Beard. 'That is exactly what we exist to do.' Critics of for-profit colleges say students can get a comparable education at community or state colleges for much less money and fret about the schools' low completion rates. 'While our tuition may be higher than community colleges, it's often lower than private nonprofit institutions and out-of-state public rates,' says Beard. 'When you factor in speed to completion and targeted career alignment, we believe we offer strong return on investment for students underserved by traditional models.' Chamberlain says its four-year graduation rate is 71.2% for full-time undergraduate students across all its campuses compared with about 50% across all four-year institutions. Partnerships at work Beard says Adtalem respects its partners' areas of expertise. 'We have to have the humility to understand that we'll never know as much about their business and the challenges they're facing as they do.' And in partnerships like the one with SSM Health, each party had to be willing to try something different in order to make the deal a win-win. In SSM's case, Wilson says, the health system had to get comfortable with giving Chamberlain students priority placement in its clinical settings, an accommodation Wilson says she was willing to make in order to help fill her hiring pipeline. 'Saying that you have a strategic relationship with one school can sometimes be difficult within the nursing profession,' she says. 'We had to overcome that hurdle internally and get people comfortable with that.' For Adtalem, the arrangement means that other health systems won't necessarily have access to recruit from the student population that commits to work at SSM. Beard advises other CEOs that their teams need to be willing to co-create and iterate for partnerships to succeed. 'We've built in a tremendous amount of flexibility to adapt the program and its features as we learn together.' Announcing Inc.'s Power Partners Does your company partner with small businesses and entrepreneurs? Every year, Inc.'s Power Partner Awards recognizes companies of all sizes that help independent companies scale. You can apply here to earn a slot on this prestigious list. The deadline is July 25.
Yahoo
02-07-2025
- Yahoo
Tempus AI (NasdaqGS:TEM) Reports Promising Earnings with Revenue Increase
Tempus AI recently saw its market presence elevated as it was added to multiple Russell indices, showcasing an enhanced visibility. The company also bolstered its strategic partnerships, collaborating with Northwestern University on Alzheimer's research using its AI platform. Despite competing dynamics in the market where technology stocks generally saw positive momentum, Tempus AI's share price increased 19% over the last quarter. This movement was supported by initiatives like the launch of a liquid biopsy assay and reports of promising earnings, which included a significant revenue increase and an upward revision of yearly financial guidance. Every company has risks, and we've spotted 3 weaknesses for Tempus AI you should know about. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent addition of Tempus AI to multiple Russell indices and its strategic collaboration with Northwestern University have significantly enhanced its market visibility and highlighted its role in cutting-edge Alzheimer's research utilizing AI. These developments could accelerate Tempus' revenue growth and elevate its earnings prospects as the company continues to expand its partnerships and refine its AI-driven precision medicine capabilities. In particular, the integration of new platforms may increase client retention, bolstering long-term revenue streams. As the company aligns with pharma giants such as AstraZeneca and Pathos, these partnerships have the potential to validate and further drive demand for its oncology models, which is a critical factor for sustained growth. Tempus AI's shares have experienced a total return of 65.22% over the past year, demonstrating strong performance relative to the broader market and significantly surpassing the US Life Sciences industry's return, which saw a decline of 19.4% over the same period. This robust performance underscores investor confidence in Tempus' growth trajectory, despite facing inherent risks such as high operational expenditures and dependency on major contracts. The current share price reflects a minor disparity compared to the consensus analyst price target of US$65.5, indicating that analysts view the stock as neutrally valued, with a difference of 7.0%. This suggests cautious optimism regarding the company's future performance. As Tempus invests heavily in data infrastructure and AI, the increased cost base may weigh on profitability in the short term. However, successful execution could lead to a shift from low-margin diagnostics to high-margin software contracts, thus enhancing earnings forecasts. Whether Tempus can achieve anticipated revenue growth of 21.71% annually remains contingent on continued expansion of its AI and data offerings, in line with industry adoption of precision medicine. Click to explore a detailed breakdown of our findings in Tempus AI's financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:TEM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
